Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Neoadjuvant PD-L1 Inhibitor Plus Anlotinib for Kidney Preservation in Complex Renal Cell Carcinoma

RenJi Hospital · 2026
ClinicalTrials.gov · Datasets · License: Public Domain · 2026
Open Source ↗
clear cell renal cell carcinoma, neoadjuvant therapy, pd-l1, anlotinib, nephron-sparing surgery, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 875654
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.